Skip to content
OpenCapital
Get started

Charles River Laboratories CRL DSA — CapEx

Other segment segments

RMS
$11.57M+58.8%
Manufacturing
$6.27M-63.7%

Similar metrics at other companies

Agilent Technologies logo
ALife Sciences and Applied Markets — Capital Expenditures
$15M-6.3%
Quest Diagnostics logo
DGXDS businesses — Segment, Expenditure, Addition to Long-Lived Assets
$2.5M+42.9%
Quest Diagnostics logo
DGXDIS business — Segment, Expenditure, Addition to Long-Lived Assets
$128.5M+25.4%
Agilent Technologies logo
ADiagnostics and Genomics — Capital Expenditures
$74.75M+41.0%
JB Hunt Transport Services logo
JBHTDCS — Segment Expenditure Addition To Long Lived Assets
$61.7M-20.2%
Bruker logo
BRKRCorporate — Segment Expenditure Addition To Long Lived Assets
$2.3M-51.1%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-4.6%—
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%—
Debt / equity1×+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's dsa — capex.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's DSA — capex?
Charles River Laboratories (CRL) reported DSA — capex of $37.51M in Q1 2026.
How has Charles River Laboratories's DSA — capex changed year-over-year?
Charles River Laboratories's DSA — capex increased by 8.7% year-over-year, from $34.52M to $37.51M.
What is the long-term trend for Charles River Laboratories's DSA — capex?
Over 2 years (2023 to 2025), Charles River Laboratories's DSA — capex has grown at a -19.4% compound annual growth rate (CAGR), from $204.89M to $132.96M.
What does DSA — capex mean?
The amount of money spent on physical assets and infrastructure to support the segment's operations.
How do you interpret DSA — capex?
High spending may signal future growth capacity, while consistently low spending could indicate underinvestment in infrastructure.
How does DSA — capex compare across companies?
Standard metric for capital-intensive industries like life sciences and research services.